Recombinant SARS-CoV M protein (aa 182-216) (E. coli) (CAT#: VReP-Wyb099)
CAT
Size
Price
Quantity
VReP-Wyb099
For Research Use Only. We do not provide direct services or products for patients.
Product Overview
SARS-CoV, Recombinant Protein, Matrix protein (30 kDa).
Source
E. coli
Tag
None
Target
SARS-CoV
Type
Viral Antigens
Applications
Used for immunoassays.
Formulation
50 mM Tris-HCl, 60 mM NaCl with 50% glycerol.
Purity
> 95% pure by SDS-PAGE.
Product Form
Liquid
Storage
Store at 2 °C to 8 °C short term, -20 °C long term.
Introduction
The SARS coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS). On April 16, 2003, following the outbreak of SARS in Asia and secondary cases elsewhere in the world, the World Health Organization (WHO) issued a press release stating that the coronavirus identified by a number of laboratories was the official cause of SARS. Samples of the virus are being held in laboratories in New York, San Francisco, Manila, Hong Kong, and Toronto. protein E is a kinesin-like motor protein that accumulates in the G2 phase of the cell cycle. Unlike other centromere-associated proteins, it is not present during interphase and first appears at the centromere region of chromosomes during prometaphase. CENPE is proposed to be one of the motors responsible for mammalian chromosome movement and/or spindle elongation.
Alternative Names
SARS (Severe Acute Respiratory Syndrome) Virus; Nidovirales; Coronaviridae; Coronavirus; SARS coronavirus; SARS; Severe acute respiratory syn